| EGF-R and overexpression of the oncogene c-erbB-2 in ovarian cancer: immunohistochemical findings and prognostic value. | ovarian, |
| Prognostic value of immunohistochemically detected HER-2/neu oncoprotein in endometrial cancer. | endometrial, |
| Overexpression of HER2/neu oncogene in pancreatic cancer correlates with shortened survival. | pancreatic, |
| Determination of amplification level of the c-erbB-2 proto-oncogene in human breast carcinomas: a comparative study between non-radioactive and radioactive labelling. | breast, |
| Prognostic significance of c-erbB-2 oncogene in axillary node-negative breast cancer. | breast, |
| Epidermal growth factor receptor and c-erbB-2 oncoprotein expression in female genital tract carcinosarcomas (malignant mixed mullerian tumors). Clinicopathologic study of 82 cases. | sarcoma, |
| Humoral and cellular responses raised against the human HER2 oncoprotein are cross-reactive with the homologous product of the new proto-oncogene, but do not protect rats against B104 tumors expressing mutated neu. | oral |
| DNA ploidy, cell kinetics, and epidermal growth factor receptor and HER2/neu oncoprotein expression in primary operable breast cancer. | breast, |
| Lack of expression of c-erbB-2 oncoprotein in human esophageal squamous cell carcinomas. | esophageal, |
| [Amplification of protooncogenes and expression of the HER2/neu oncogene in invasive breast cancer]. | breast, |
| C-erbB-2 oncoprotein expression in operable non-small cell lung cancer. | lung, |
| Evaluation of HER-2 neu oncoprotein expression as a prognostic indicator of local recurrence in conservatively treated breast cancer: a case-control study. | breast, |
| C-erbB-2 oncoprotein in the sera and tissue of patients with breast cancer. Utility in prognosis. | breast, |
| Relationship between c-erbB-2 oncoprotein, epidermal growth factor receptor, and estrogen receptor expression in patients with ductal breast carcinoma. Association with tumor phenotypes. | breast, |
| Variations in c-erbB-2 proto-oncogene status in breast cancer tumors as detected by two different cDNA probes. | breast, |
| FISH detection of HER-2/neu oncogene amplification in early onset breast cancer. | breast, |
| [Immunoenzymatic assays of c-erbB-2 oncoprotein and epidermal growth factor receptor in breast cancer: correlation with clinical and biological parameters]. | breast, |
| Amplifications of oncogene erbB-2 and chromosome 20q in breast cancer determined by differentially competitive polymerase chain reaction. | breast, |
| Laminin activates the p185HER2 oncoprotein and mediates growth inhibition of breast carcinoma cells. | breast, |
| Mechanisms of escape from CD8+ T-cell clones specific for the HER-2/neu proto-oncogene expressed in ovarian carcinomas: related and unrelated to decreased MHC class 1 expression. | ovarian, |